Literature DB >> 2464527

Nucleotide sequence of mouse EndoA cytokeratin cDNA reveals polypeptide characteristics of the type-II keratin subfamily.

T Morita1, M L Tondella, Y Takemoto, K Hashido, Y Ichinose, M Nozaki, A Matsushiro.   

Abstract

EndoA cytokeratin (EndoA) belongs to a family of intermediate filaments (IFs) and is coordinately expressed with EndoB cytokeratin during early mouse embryogenesis. We have isolated and sequenced a cDNA from a library constructed from mRNA of parietal yolk sac-like cells, PYS-2, which are derived from mouse teratocarcinoma. Sequence analysis reveals that EndoA is composed of 490 amino acids, its Mr is 54,362, and it contains a central alpha-helical coiled-coil structure flanked by non-alpha-helical domains. The amino acid sequence of EndoA is highly homologous with human cytokeratin No. 8 (93%) and with bovine cytokeratin No. 8 (91%) not only in the central domain, but also in its tail portion, which is less conserved among other intermediate filaments. A comparison with the other cytokeratin proteins characterizes this polypeptide as a non-epidermal type of cytokeratin of the basic (type-II) subfamily. The C-terminal sequence of EndoA is identical to that of human and bovine cytokeratin No. 8 and also highly conserved in other intermediate filaments (desmin, vimentin, glial fibrillary acidic protein and EndoB). It suggests that these may be involved in interaction with some cell component(s), or in more general roles to form IFs. The N-terminal head region is rich in Ser residues including possible phosphorylation sites.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2464527     DOI: 10.1016/0378-1119(88)90604-x

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  Regulation of keratin and integrin gene expression in cancer and drug resistance.

Authors:  N Daly; P Meleady; D Walsh; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

2.  Analysis of gene expression in the preimplantation mouse embryo: use of mRNA differential display.

Authors:  J W Zimmermann; R M Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 3.  Oncogenic regulation and function of keratins 8 and 18.

Authors:  R G Oshima; H Baribault; C Caulín
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

4.  Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family.

Authors:  P Oettgen; R M Alani; M A Barcinski; L Brown; Y Akbarali; J Boltax; C Kunsch; K Munger; T A Libermann
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

5.  Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer.

Authors:  P M Siegel; E D Ryan; R D Cardiff; W J Muller
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

6.  Cytokeratin 8 released by breast carcinoma cells in vitro binds plasminogen and tissue-type plasminogen activator and promotes plasminogen activation.

Authors:  T A Hembrough; K R Kralovich; L Li; S L Gonias
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

7.  The promoter of the endo A cytokeratin gene is activated by a 3' downstream enhancer.

Authors:  Y Takemoto; Y Fujimura; M Matsumoto; Y Tamai; T Morita; A Matsushiro; M Nozaki
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

8.  One of two Ets-binding sites in the cytokeratin EndoA enhancer is essential for enhancer activity and binds to Ets-2 related proteins.

Authors:  Y Fujimura; H Yamamoto; F Hamazato; M Nozaki
Journal:  Nucleic Acids Res       Date:  1994-02-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.